OBIO® and IPON Renew Multi-Year Collaboration to Advance Ontario’s Sovereign IP Capacity OBIO® and Intellectual Property Ontario (IPON) have renewed their memorandum of understanding (MOU) to ensure that Ontario’s next generation of companies developing innovative human health products continue to access optimal…
Massive Bio and Just Worldwide Announce Strategic Partnership to Connect More Cancer Patients to Clinical Trials Massive Bio, the global leader in AI-driven clinical trial matching for cancer patients, and Just Worldwide, a leading global fieldwork and market research provider…
IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities IQVIA a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, is advancing its strategic…
Next Health in Peoria Hosting Grand Opening, Bringing Advanced Longevity & Preventive Health Services to Arizona Next Health, the world’s most advanced and comprehensive brand of health optimization and longevity centers, invites the community and media to its newest location in…
Trinseo Takes Proactive Step to Strengthen Financial Foundation and to Drive Long-Term Sustainable Growth Trinseo PLC a specialty material solutions provider, announced that it entered into a Restructuring Support Agreement with parties that hold a majority of its debt. This…
Dyno Therapeutics Announces Expanded Frontiers Network and Second Annual Genetic Agency Technology Conference (GATC) Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, announced significant updates to two mission-driven initiatives:…
Osmo, the Olfactory Technology Company, Opens New Headquarters and Manufacturing Facility in Elizabeth, New Jersey Osmo, the olfactory technology company, marked the opening of its 60,000-square-foot manufacturing facility in Elizabeth, New Jersey. The facility, where Osmo will expand the commercialization…
Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes Mirum Pharmaceuticals, Inc. a leading rare disease company, announced the pricing of its offering of $600.0 million aggregate principal amount of 0.00% convertible senior…
Transition Industries and the Mexican Forestry Commission (CONAFOR) Sign Collaboration Agreement for Wetlands Conservation in Sinaloa Transition Industries LLC, developer of the Pacifico Mexinol project, and Mexico’s National Forestry Commission (Comisión Nacional Forestal, CONAFOR) signed a collaboration agreement to implement an Environmental…
GC Biopharma Presents New Data at CIS 2026 to Expand Analytical Understanding of IVIG Product Characteristics GC Biopharma USA, Inc., a leader in plasma-derived products, announced the presentation of new data at the 2026 Clinical Immunology Society (CIS) Annual Meeting…
GE HealthCare’s next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting,GE HealthCare’s announced advancements…
Cellares and ProTgen Partner to Automate Manufacturing for ProT-096, a Novel Progenitor T Cell Therapy Designed to Restore Immune Competence Cellares, the first Integrated Development and Manufacturing Organization and ProTgen, a biotechnology company pioneering targeted Notch activators to reactivate the…